Qube Research & Technologies LTD Checkpoint Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $1.77 $40,558 - $74,009	-41,813 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$1.53 - $3.25 $2,495 - $5,300	-1,631 Reduced 3.75%	41,813 $74,000
Q4 2021 Feb 01, 2022	BUY	$2.68 - $4.46 $116,429 - $193,760	43,444 New	43,444 $135,000
Q3 2021 Nov 12, 2021	SELL	$2.5 - $3.53 $57,660 - $81,415	-23,064 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.36 - $3.2 $54,431 - $73,804	23,064 New	23,064 $68,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $297M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.